CATALYSTYahoo • 1d ago
Why UnitedHealth Stock Can Still Gain After This Year’s 24% RallyThe health insurer’s third-quarter results helped reinforce the stock’s momentum.
Why UNH Stock advanced +0.94% Today — RQD Quant Desk Flash
$410.91 +0.94% NYSE • Public Delayed / 60s Snapshot
UnitedHealth Group Incorporated (UNH) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. Cash-backed 11% return on capital boosted by $1.37B (36C10G24K0111) in obligated U.S. government contracts. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
ROARABLE B- • BUY
Cap $364.66B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERBUY • B-
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw B- · Rk B+
Each axis scored 0–20
12M PRICE TARGET CONE+19.2% Base Target
WHALE OPTIONS TUG-OF-WAR:27% Call Buyers ($874.0K)
73% PutsMax Pain: $400.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why UNH Stock advanced +0.94% Today — RQD Quant Desk Flash
UnitedHealth Group Incorporated (UNH) advanced +0.94% to $410.91 as options desks priced 27% call premium vs. 73% put protection around the $400 max-pain magnet. Cash-backed 11% return on capital boosted by $1.37B (36C10G24K0111) in obligated U.S. government contracts.
- ▸Technical Tape: Trading at 75% of its 52-week range ($255.97 – $461.62) with RSI-14 at 56 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $874015 in bullish call flow vs. $2.3M in put flow (Put/Call 0.88x, implied earnings swing ±6.7%).
- ▸Primary SEC / Cross-Feed Trigger: UNH Awarded $1.37B Department of Veterans Affairs Prime Contract (1.25% of Annual Revenue Across 5 Obligations)
Live UNH Headlines & Catalysts
CATALYSTSeekingAlpha • 1d ago
Dividend Income Report: +15.25% And A Listener's Portfolio RoastThis month I tried something different on the podcast - a listener sent me one of his portfolios and asked me to roast it. Read more here.
MARKET WIREYahoo • 1d ago
What UnitedHealth Group Bulls Got RightIf you had been weighing UnitedHealth Group on 1 January 2026, you were staring at a business fresh off a difficult 2025, with analysts split between a Medicare margin squeeze and an AI powered recovery. Investors who he
MARKET WIREYahoo • 1d ago
BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS SaysBridgeBio Pharma's (BBIO) heart disorder drug Attruby faces near-term tailwinds from the likely appr
CATALYSTYahoo • 1d ago
1 safe-and-steady stock to research further and 2 we find riskyStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
CATALYSTYahoo • 1d ago
$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in DividendsDividends keep paying whether you sell or not, and four healthcare giants quietly generate serious retirement income while you sleep. But not every yield here is as safe as it looks.
CATALYSTYahoo • 1d ago
BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%Key TakeawaysBrightSpring Health Services stock jumped 12% as adjusted EBITDA rose 42% and 2026 guidance went up. Gross profit per script rose 27% in what management calls the peak year for Medicare’s drug-price negotiat
RISK WATCHYahoo • 1d ago
As the Nasdaq wobbles on capex, this Buffett strategy went 15-for-15Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
CATALYSTYahoo • 2d ago
THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View RaisedTenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.
MARKET WIREYahoo • 2d ago
UnitedHealth is bouncing back, but a major risk remainsMedicare is back in range. Commercial plans, Medicaid, and AI spending are the next tests.
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Senior Cash-Flow & Income Strategist
Cash-Fortress Compounders: Collecting Safe Yield & Upside in UNH & Top A-Rated Leaders
- ✓12-month Bull/Base/Bear fair-value walkthrough on UNH and its top sector rival
- ✓The Top 5 Roarable A-Rated cash compounders with heavy executive & 13F accumulation
- ✓Includes free daily Morning Market Weather & signal upgrade/downgrade dispatch
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
UNH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +10.36%⚡ TESTING RESISTANCE
2026-10-30O $419.0H $420.9L $404.3C $407.0VOL 20.32M
RES: $407.5SUP: $348.4SMA50: $390.2SMA200: $362.8
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
UNH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
-1.94% YoY Shares
SEC XBRL FY2024 → FY2025: Net share cannibal / buyback tailwind.
Reverse-DCF Expectations Hurdle (#30)
19.5%/yr Implied 5Y Growth
vs. +6.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on UNH today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
LLY → UNH Confirmed Filing
FDA label expansions of GLP-1 drugs into cardiovascular risk reduction, obstructive sleep apnea, and kidney disease unlock Medicare Part D statutory coverage, elevating UnitedHealthcare specialty drug costs.
AI Analyst Theses, Washington Policy & Company Video
🏛️ COMMENT_RULEMAKING: CMS Contract Year Medicare Advantage Capitation Benchmark & Part D GLP-1 Coverage Rulemaking (Centers for Medicare & Medicaid Services (HHS — 42 CFR Parts 422 & 423))
🎬 No recent verified company-specific video clip queued for UNH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
UNH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is UNH stock moving today?
Why UNH Stock advanced +0.94% Today — RQD Quant Desk Flash. Cash-backed 11% return on capital boosted by $1.37B (36C10G24K0111) in obligated U.S. government contracts.